| 473 |
Energy deposition from internalized Ra-226 decay lower oxygen binding capacity of hemocyanin |
Danielle Beaton |
BY-SA |
1686: Deposition of Energy
|
2 AOs
|
|
|
| 472 |
DNA adduct formation leading to kidney failure |
Manoe Janssen |
BY-SA |
373: Formation, Pro-mutagenic DNA Adducts
|
759: Increased, Kidney Failure
|
|
|
| 471 |
Neuron defect induced early behavioral change |
Woo-Keun Kim |
BY-SA |
2195: Increase, CNS Neural cell death
|
7 AOs
|
|
|
| 470 |
Deposition of energy leads to abnormal vascular remodeling |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2069: Occurrence, Abnormal Vascular Remodeling
|
WPHA/WNT Endorsed |
1.89 |
| 469 |
Reactive oxygen speicies overproduction leading to increased digestive morbidity and mortality in generation population |
Ruiyang Ding |
BY-SA |
None
|
None
|
|
|
| 468 |
Binding of SARS-CoV-2 to ACE2 leads to hyperinflammation (via cell death) |
Laure-Alix Clerbaux |
BY-SA |
1739: Binding to ACE2
|
1868: Hyperinflammation
|
|
|
| 467 |
Knickkopf leading to mortality |
Donggon Yoo |
BY-SA |
2058: Decrease, 20-hydroxyecdysone
|
None
|
|
|
| 466 |
Doda decarboxylase leading to mortality |
Donggon Yoo |
BY-SA |
2051: Decrease, Tyrosine
|
None
|
|
|
| 465 |
Alcohol dehydrogenase leading to reproductive dysfunction |
Donggon Yoo |
BY-SA |
2045: Increase, Alcohol dehydrogenase
|
None
|
|
|
| 464 |
Calcium overload in dopaminergic neurons of the substantia nigra leading to parkinsonian motor deficits |
Julia Meerman |
BY-SA |
5 MIEs
|
896: Parkinsonian motor deficits
|
|
|
| 463 |
The AOP framwork on silica nanopariticles induced hepatoxicity |
Tianyu Li |
BY-SA |
None
|
None
|
|
|
| 462 |
Activation of reactive oxygen species leading the atherosclerosis |
Hiromi Ohara |
BY-SA |
1115: Increase, Reactive oxygen species
|
None
|
|
|
| 461 |
Deposition of ionising energy leads to population decline via impaired oogenesis and spermatogenesis |
Knut Erik Tollefsen |
BY-SA |
None
|
None
|
|
|
| 460 |
Antagonism of Smoothened receptor leading to orofacial clefting |
Jacob Reynolds |
BY-SA |
2027: Antagonism, Smoothened receptor
|
2042: Increase, Orofacial clefting
|
Under Review |
1.101 |
| 459 |
AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Prakash Patel |
Open for adoption |
18: Activation, AhR
|
402: Cognitive function, decreased
|
|
|
| 458 |
AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Prakash Patel |
Open for adoption |
18: Activation, AhR
|
402: Cognitive function, decreased
|
|
|
| 457 |
Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine |
Simon Thomas |
Open for adoption |
2118: Succinate dehydrogenase, inhibited
|
2119: Increase, Insulin resistance
|
|
|
| 456 |
Aryl hydrocarbon receptor activation leading to early life stage mortality via sox9 repression induced cardiovascular toxicity |
Prarthana Shankar |
BY-SA |
18: Activation, AhR
|
947: Increase, Early Life Stage Mortality
|
WPHA/WNT Endorsed |
1.27 |
| 455 |
Aryl hydrocarbon receptor activation leading to early life stage mortality via sox9 repression induced impeded craniofacial development |
Prarthana Shankar |
BY-SA |
18: Activation, AhR
|
2 AOs
|
WPHA/WNT Endorsed |
1.27 |
| 454 |
PM2.5-related AOP frameworks on liver diseases |
Zhou Du |
BY-SA |
None
|
None
|
|
|
| 453 |
Reactive oxygen species and subsequent oxidative stress lead to increased incidence of digestive morbidity and mortality in the general population |
Ruiyang Ding |
BY-SA |
None
|
None
|
|
|
| 452 |
Adverse outcome pathway of PM-induced respiratory toxicity |
li qing |
BY-SA |
2007: Non-coding RNA expression profile alteration
|
2008: Chronic obstructive pulmonary disease
|
|
|
| 451 |
Interaction with lung resident cell membrane components leads to lung cancer |
Penny Nymark |
BY-SA |
1495: Substance interaction with the lung resident cell membrane components
|
1670: Lung cancer
|
|
|
| 450 |
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality |
SAROJ AMAR |
BY-SA |
12: Acetylcholinesterase (AchE) Inhibition
|
2 AOs
|
|
|
| 449 |
Ceramide synthase inhibition leading to neural tube defects |
Lola Bajard |
BY-SA |
2023: Inhibition of Ceramide Synthase
|
1561: Neural tube defects
|
|
|